Side-by-side comparison of AI visibility scores, market position, and capabilities
Rochester NY HCM and payroll platform (NASDAQ: PAYX) at $5.5B+ FY2025 revenue; $4.1B Paycor HCM acquisition (April 2025) adding 49,000 clients competing with ADP for US small and mid-market HR platform.
Paychex, Inc. is a Rochester, New York-based human capital management (HCM) and payroll company — publicly traded on NASDAQ (NASDAQ: PAYX) as an S&P 500 component — serving nearly 800,000 clients across the United States and Europe with payroll processing, HR technology, employee benefits administration, retirement services, insurance services, and PEO/ASO solutions through the Paychex Flex cloud platform. In fiscal year 2025, Paychex reported annual revenue exceeding $5.5 billion with more than 16,000 employees. In April 2025, Paychex completed the acquisition of Paycor HCM for approximately $4.1 billion — the largest acquisition in Paychex history — adding 2,900 employees, 49,000 clients, and HCM capabilities for 2.7 million employees, significantly expanding Paychex's presence in the mid-market and enterprise segments. AI-powered Paychex Recruiting CoPilot and HR analytics tools reflect Paychex's technology investment. Founded in 1971 by Tom Golisano in Rochester with $3,000 in initial capital, Paychex pioneered affordable payroll outsourcing for small businesses.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.